Aktive farmaceutiske ingredienser
Gestagen og østrogen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolon | In-house |
Kosher | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetat | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Østradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
Østradiol Valerat | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestan | EP/USP | Under R&D | 107868-30-4 |
androgen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateronacetat | CP/USP | DMF/WC | 154229-18-2 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
Testosteron Cypionate | USP | Under R&D | 58-20-8 |
DHEA (prasteron) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF i gang | 19608-29-8 |
Kortikalt hormon | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Budesonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF/GMP | 638-94-8 |
Eplerenon | EP | CEP i gang | 107724-20-9 |
Methylprednisolon | CP/EP/USP | DMF/GMP | 83-43-2 |
Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
Flutikasonfuroat | In-house | DMF i gang | 397864-44-7 |
Mometasonfuroat |
EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
Andre | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Oxcarbazepin | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepinacetat | In-house | DMF | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochlorid | USP | DMF | 175865-59-5 |
Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF/FDA | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalat | EP/USP/CP | DMF i gang | 219861-08-2 |
Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
Luliconazol | In-house | DMF | 187164-19-8 |
Apalutami | In-house | DMF i gang | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | DMF i gang | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
MELLEMMÅLTID |
In-house |
DMF i gang |
203787-91-1 |
Progesteron har EP, USP, CP, JP, IP og KP specifikationer.CEP tilgængelig, EU-GMP,FDA godkendt.
Finasteride har EP, USP, CP, IP, JP specifikationer.CEP tilgængelig, FDA, PMDA og GMP godkendt.
Budesonid har USP, EP specifikationer. CEP, GMP og FDA godkendt.
Dutasteride har EP, USP, CP, IP, JP specifikation. CEP og FDA tilgængelige.
Desonide har USP- og EP-specifikationer. DMF tilgængelig.
Methylprednisolon har USP, EP, IP, JP og KP specifikationer. DMF og toilet til rådighed.